HOME Sitemap Contact Us
R&DPlatform technology


Penta amino acid mutated bispecific antibody

A NEXT generation bispecific antibody

platform technology.

  • Natural IgG-like properties: stability, affinity, immunogenicity and PK
  • Good manufacturability with high yield and purity (no mispairing)
  • Diverse applications with minimal engineering
  • Clinical evaluation of the platform on-going
Penta AA mutated bispecific antibody at CH3 domain